Assessment of Safety, Tolerability, Radiation Dosimetry, Imaging Properties of 89Zr-girentuximab in Patients With NMIBC
Clinical trial NCT04897763 · COMPLETED
Trial details
- NCT number
- NCT04897763
- Sponsor
- Institut Cancerologie de l'Ouest
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-15
- Primary completion
- 2022-08-24
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.